<DOC>
	<DOCNO>NCT03007394</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety lorcaserin treatment cocaine use disorder .</brief_summary>
	<brief_title>Lorcaserin Treatment Cocaine Use Disorder</brief_title>
	<detailed_description>This 19-week , multi-center , randomize , Phase 2 clinical study compare efficacy lorcaserin ( 10mg , b.i.d ) match placebo treatment cocaine use disorder . Up 3 week allow Screening Period 13-week treatment phase , 3-week follow-up period , schedule visit Study week 14 16 .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Has DSM5 diagnosis current cocaine use disorder verify Structured Clinical Interview DSM5 Is seek treatment cocaine use disorder Is able understand provide write informed consent Has use cocaine least 1 day last 30 day prior screen Has complete psychological assessment procedure screen period If female , pregnant , lactating , unable conceive OR must agree use acceptable method birth control Has total body weight great 110 pound body mass index great 20 Contact site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cocaine Use Disorder</keyword>
</DOC>